ArticleCancer immunology, immunotherapy : CII2025

Improved efficacy of concurrent anti-PD1 antibody plus AVD versus ABVD in patients with newly diagnosed early unfavorable and advanced stage classic Hodgkin lymphoma: a retrospective matched cohort study.

Mengqiu Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.